Aclaris Therapeutics (ACRS)
Aclaris Therapeutics (ACRS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- ACRS last traded at $3.44 on 2026-11-20, -1.71% for the session.
- Aclaris Therapeutics: market cap $545.63M, revenue $6.40M over the last four quarters.
- Over the past year ACRS returned 39.84%, with a year-to-date return of 14.29%.